- Home
- SPT vs TMDX Comparison
SPT vs TMDX Comparison
Compare SPT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPT
- TMDX
- Stock Information
- Founded
- SPT 2010
- TMDX 1998
- Country
- SPT United States
- TMDX United States
- Employees
- SPT N/A
- TMDX N/A
- Industry
- SPT Computer Software: Prepackaged Software
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SPT Technology
- TMDX Health Care
- Exchange
- SPT Nasdaq
- TMDX Nasdaq
- Market Cap
- SPT 1.9B
- TMDX 2.3B
- IPO Year
- SPT 2019
- TMDX 2019
- Fundamental
- Price
- SPT $22.54
- TMDX $73.11
- Analyst Decision
- SPT Buy
- TMDX Buy
- Analyst Count
- SPT 15
- TMDX 10
- Target Price
- SPT $33.85
- TMDX $118.44
- AVG Volume (30 Days)
- SPT 681.0K
- TMDX 761.9K
- Earning Date
- SPT 05-01-2025
- TMDX 04-29-2025
- Dividend Yield
- SPT N/A
- TMDX N/A
- EPS Growth
- SPT N/A
- TMDX N/A
- EPS
- SPT N/A
- TMDX 1.01
- Revenue
- SPT $405,908,000.00
- TMDX $441,540,000.00
- Revenue This Year
- SPT $12.30
- TMDX $25.33
- Revenue Next Year
- SPT $13.09
- TMDX $20.53
- P/E Ratio
- SPT N/A
- TMDX $67.59
- Revenue Growth
- SPT 21.66
- TMDX 82.74
- 52 Week Low
- SPT $21.51
- TMDX $55.00
- 52 Week High
- SPT $59.04
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- SPT 29.79
- TMDX 57.27
- Support Level
- SPT $21.51
- TMDX $65.90
- Resistance Level
- SPT $25.81
- TMDX $73.68
- Average True Range (ATR)
- SPT 0.95
- TMDX 3.45
- MACD
- SPT -0.04
- TMDX 0.24
- Stochastic Oscillator
- SPT 23.96
- TMDX 93.25
About SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. The firm generates majority revenue from software subscriptions.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.